VeriMomVeriMom

Безопасен ли copper heptapeptide-14 pantothenate при беременности?

No harmonised CLP reproductive classification or SCCS/CIR safety assessment was identified for this specific ingredient name; no peer‑reviewed reproductive or developmental toxicity data located in the cited sources. Topical copper‑peptide complexes and peptide salts generally have low dermal systemic bioavailability, so exposure from normal cosmetic use is expected to be negligible. Sources checked: ECHA Annex VI (harmonised CLP) = no entry; CIR/SCCS = no safety assessment for this exact ingredient; PubMed = no reproductive/developmental studies found.

Ингредиенты
copper heptapeptide-14 pantothenate
БЕЗ ИЗВЕСТНЫХ РИСКОВ
100
/100
0

Pregnancy-safe products containing copper heptapeptide-14 pantothenate

Related ingredients

Frequently asked questions

Безопасен ли copper heptapeptide-14 pantothenate при беременности?
No harmonised CLP reproductive classification or SCCS/CIR safety assessment was identified for this specific ingredient name; no peer‑reviewed reproductive or developmental toxicity data located in the cited sources. Topical copper‑peptide complexes and peptide salts generally have low dermal systemic bioavailability, so exposure from normal cosmetic use is expected to be negligible. Sources checked: ECHA Annex VI (harmonised CLP) = no entry; CIR/SCCS = no safety assessment for this exact ingredient; PubMed = no reproductive/developmental studies found.
Безопасен ли copper heptapeptide-14 pantothenate при грудном вскармливании?
No evidence of lactation/breastmilk transfer or reproductive hazard for this specific ingredient in the available regulatory and literature sources. Given the lack of systemic reproductive/toxicological data and expected low dermal absorption of peptide complexes, systemic exposure in lactating persons from cosmetic topical use is expected to be negligible. Sources checked: ECHA Annex VI, CIR, PubMed, CosIng, PubChem.
Безопасен ли copper heptapeptide-14 pantothenate для кожи малыша?
No infant‑specific toxicity or dermal absorption studies were identified. By default there is no evidence of reproductive or developmental hazard, but infant skin has higher permeability; while adult topical exposure is assessed as negligible, a precautionary modest increase in exposure score (e=1) is applied for 0–3 yr skin due to the immature barrier and higher surface‑area‑to‑weight ratio. No harmonised CLP flags or specific SCCS/CIR guidance for infant use were found.
Как VeriMom оценивает copper heptapeptide-14 pantothenate?
VeriMom оценивает copper heptapeptide-14 pantothenate в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
Какие безопасные альтернативы copper heptapeptide-14 pantothenate при беременности?
См. наш список безопасных альтернатив copper heptapeptide-14 pantothenate с аналогичной функцией и классификацией без известных рисков.

Проверь любой состав за 2 секунды

Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.

Медицинская оговорка

Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.

Получите полный доступ в приложении VeriMom